Cagrilintide is a long-acting analogue of amylin. It is being tested to treat obesity and type 2 diabetes by itself and in combination with semaglutide as cagrilintide/semaglutide.[1][2][3][4][5][6]
This pharmacology-related article is a stub. You can help Wikipedia by expanding it.
Lokasi Pengunjung: 3.144.232.206